Amgen INC (AMGN) — 8-K Filings

All 8-K filings from Amgen INC. Browse 10 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (10)

8-K Filing — Nov 4, 2025
Amgen Files 8-K on Financials and Exhibits — Aug 5, 2025 Risk: low
Amgen Inc. filed an 8-K on August 5, 2025, reporting on its results of operations and financial condition, and including financial statements and exhibits. The
Amgen Inc. Files 8-K for Security Holder Vote — May 27, 2025 Risk: low
On May 23, 2025, Amgen Inc. filed an 8-K report detailing the submission of matters to a vote of its security holders. The filing does not disclose specific det
Amgen Inc. Files 8-K on Financials — May 1, 2025 Risk: low
Amgen Inc. filed an 8-K on May 1, 2025, reporting on its results of operations and financial condition, and including financial statements and exhibits. The fil
Amgen Inc. Files 8-K on Financials — Feb 4, 2025 Risk: low
Amgen Inc. filed an 8-K on February 4, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibi
Amgen Inc. Files 8-K on Financials — Oct 30, 2024 Risk: low
Amgen Inc. filed an 8-K on October 30, 2024, reporting on its Results of Operations and Financial Condition, as well as Financial Statements and Exhibits. The f
Amgen Inc. Files 8-K for Operations and Financials — Aug 6, 2024 Risk: low
On August 6, 2024, Amgen Inc. filed an 8-K report to disclose information regarding its results of operations and financial condition, as well as financial stat
Amgen Inc. Announces Board Changes and Executive Appointments — Jun 3, 2024 Risk: low
On May 31, 2024, Amgen Inc. filed an 8-K report detailing the departure of director Robert Bradway and the election of new directors, including David E.I. Pyott
Amgen Inc. Files 8-K on Financials — May 2, 2024 Risk: low
On May 2, 2024, Amgen Inc. filed an 8-K report detailing its financial results and condition. The filing includes financial statements and exhibits related to i
AMGEN FILES 8-K ON FINANCIAL RESULTS, EXHIBITS — Feb 6, 2024
Amgen Inc. filed an 8-K on February 6, 2024, to report its results of operations and financial condition, along with related financial statements and exhibits.

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX